BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35347250)

  • 1. Rapid and highly sensitive approach for multiplexed somatic fusion detection.
    Abbou S; Finstuen-Magro S; McDannell B; Feenstra M; Ward A; Shulman DS; Geoerger B; Duplan J; Comeau H; Janeway KA; Klega K; Crompton BD
    Mod Pathol; 2022 Aug; 35(8):1022-1033. PubMed ID: 35347250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay.
    Lanic MD; Le Loarer F; Rainville V; Sater V; Viennot M; Beaussire L; Viailly PJ; Angot E; Hostein I; Jardin F; Ruminy P; Laé M
    Mod Pathol; 2022 May; 35(5):649-663. PubMed ID: 35075283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ChildSeq-RNA: A next-generation sequencing-based diagnostic assay to identify known fusion transcripts in childhood sarcomas.
    Qadir MA; Zhan SH; Kwok B; Bruestle J; Drees B; Popescu OE; Sorensen PH
    J Mol Diagn; 2014 May; 16(3):361-70. PubMed ID: 24517889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.
    Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA
    Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of lung fusions using a multiplex RT-PCR next generation sequencing-based approach: a multi-institutional research study.
    Vaughn CP; Costa JL; Feilotter HE; Petraroli R; Bagai V; Rachiglio AM; Marino FZ; Tops B; Kurth HM; Sakai K; Mafficini A; Bastien RRL; Reiman A; Le Corre D; Boag A; Crocker S; Bihl M; Hirschmann A; Scarpa A; Machado JC; Blons H; Sheils O; Bramlett K; Ligtenberg MJL; Cree IA; Normanno N; Nishio K; Laurent-Puig P
    BMC Cancer; 2018 Aug; 18(1):828. PubMed ID: 30115026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
    Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
    Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed automated digital quantification of fusion transcripts: comparative study with fluorescent in-situ hybridization (FISH) technique in acute leukemia patients.
    Akhter A; Mughal MK; Elyamany G; Sinclair G; Azma RZ; Masir N; Shuib S; Rashid-Kolvear F; Shabani-Rad MT; Stewart DA; Mansoor A
    Diagn Pathol; 2016 Sep; 11(1):89. PubMed ID: 27632978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay.
    Drieux F; Ruminy P; Sater V; Marchand V; Fataccioli V; Lanic MD; Viennot M; Viailly PJ; Sako N; Robe C; Dupuy A; Vallois D; Veresezan L; Poullot E; Picquenot JM; Bossard C; Parrens M; Lemonnier F; Jardin F; de Leval L; Gaulard P
    J Mol Diagn; 2021 Aug; 23(8):929-940. PubMed ID: 34147695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.
    Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
    Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of RNA-Based Next-Generation Sequencing Assays for the Detection of NTRK Gene Fusions.
    Park HJ; Baek I; Cheang G; Solomon JP; Song W
    J Mol Diagn; 2021 Nov; 23(11):1443-1451. PubMed ID: 34756276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoma Subgrouping by Detection of Fusion Transcripts Using NanoString nCounter Technology.
    Sheth J; Arnoldo A; Zhong Y; Marrano P; Pereira C; Ryall S; Thorner P; Hawkins C; Somers GR
    Pediatr Dev Pathol; 2019; 22(3):205-213. PubMed ID: 30089422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA Capture Sequencing and RT-qPCR for the Detection of Pathognomonic, Novel, and Secondary Fusion Transcripts in FFPE Tissue: A Sarcoma Showcase.
    Decock A; Creytens D; Lefever S; Van der Meulen J; Anckaert J; De Ganck A; Deleu J; De Wilde B; Fierro C; Kuersten S; Luypaert M; Rottiers I; Schroth GP; Steyaert S; Vanderheyden K; Vanden Eynde E; Verniers K; Verreth J; Van Dorpe J; Vandesompele J
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a Next-Generation Sequencing Assay Targeting RNA for the Multiplexed Detection of Fusion Transcripts and Oncogenic Isoforms.
    Sussman RT; Oran AR; Paolillo C; Lieberman D; Morrissette JJD; Rosenbaum JN
    Arch Pathol Lab Med; 2020 Jan; 144(1):90-98. PubMed ID: 31211614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma.
    Zhu G; Benayed R; Ho C; Mullaney K; Sukhadia P; Rios K; Berry R; Rubin BP; Nafa K; Wang L; Klimstra DS; Ladanyi M; Hameed MR
    Mod Pathol; 2019 May; 32(5):609-620. PubMed ID: 30459475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly sensitive fusion detection using plasma cell-free RNA in non-small-cell lung cancers.
    Hasegawa N; Kohsaka S; Kurokawa K; Shinno Y; Takeda Nakamura I; Ueno T; Kojima S; Kawazu M; Suehara Y; Ishijima M; Goto Y; Kojima Y; Yonemori K; Hayashi T; Saito T; Shukuya T; Takahashi F; Takahashi K; Mano H
    Cancer Sci; 2021 Oct; 112(10):4393-4403. PubMed ID: 34310819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA; Frohnauer J; Merkelbach-Bruse S; Schildhaus HU; Dimmler A; Schubert T; Boltze C; König H; Fuchs F; Sirbu H; Rieker RJ; Agaimy A; Hartmann A; Haller F
    Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
    Guseva NV; Tanas MR; Stence AA; Sompallae R; Schade JC; Bossler AD; Bellizzi AM; Ma D
    Cancer Genet; 2016; 209(7-8):303-12. PubMed ID: 27292373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
    Solomon JP; Linkov I; Rosado A; Mullaney K; Rosen EY; Frosina D; Jungbluth AA; Zehir A; Benayed R; Drilon A; Hyman DM; Ladanyi M; Sireci AN; Hechtman JF
    Mod Pathol; 2020 Jan; 33(1):38-46. PubMed ID: 31375766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Fusion Identification Using Anchor-Based Multiplex PCR and Next-Generation Sequencing.
    Cheng YW; Meyer A; Jakubowski MA; Keenan SO; Brock JE; Azzato EM; Weindel M; Farkas DH; Rubin BP
    J Appl Lab Med; 2021 Jul; 6(4):917-930. PubMed ID: 33537766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
    Haley L; Parimi V; Jiang L; Pallavajjala A; Hardy M; Yonescu R; Morsberger L; Stinnett V; Long P; Zou YS; Gocke CD
    J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.